v3.26.1
Segment Reporting - Schedule of Reconciliation of Adjusted EBITDA (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Abstract]        
Adjusted EBITDA $ 348.0 $ 318.6 $ 696.8 $ 632.2
Stock-based compensation (13.8) (14.3) (25.3) (23.8)
Depreciation and amortization (90.4) (79.9) (177.7) (159.1)
Loss on disposal or impairment of assets (2.1) (0.3) (2.4) (0.5)
Loss on early extinguishment of debt (3.2) 0.0 (3.4) 0.0
Interest expense and amortization of debt discounts and fees (32.8) (30.4) (64.6) (62.2)
Net income attributable to noncontrolling interests 53.5 42.8 107.2 87.8
Change in fair market value of marketable securities 2.4 0.3 2.2 1.0
Gain on sale of Gamma Knife 0.0 0.0 17.5 0.0
Income from continuing operations before income tax expense $ 261.6 $ 236.8 $ 550.3 $ 475.4